semaglutide treatment the villages fl Personalized Compounded Semaglutide in The

The injectable drug, initially only used as diabetes medication, is the first drug since Saxenda (2014) approved to treat chronic weight management in the 70% of American adults who are obese or overweight

Tirzepatide produced 20.2% weight loss compared to 13.7% for semaglutide at 72 weeks

Potential vision problems linked to Ozempic use: Temporary issues: Blurred vision Difficulty focusing Increased sensitivity to light Potentially permanent damage: Worsening of diabetic retinopathy Development of macular edema Optic nerve damage Exacerbation of pre-existing conditions: Acceleration of diabetic eye disease Potential worsening of glaucoma or other chronic eye conditions If youve experienced any vision changes while using Ozempic, its crucial to seek immediate medical attention

Clinical trials show that higher doses of semaglutide typically lead to greater weight reduction

Accessed January 22, 2026